JCI - Comments

Submit a comment

Cyclic 3′,5′-adenosine monophosphate in human blood platelets: II. Effect of N⁶-2′-0-dibutyryl cyclic 3′,5′-adenosine monophosphate on platelet function

Published January 1, 1971
Citation Information: J Clin Invest. 1971;50(1):131-141. https://doi.org/10.1172/JCI106467.

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

Comments appear on the Journal’s website and are linked from the original article’s web page.
Authors are notified by email if their comments are posted.
The Journal reserves the right to edit comments for length and clarity.
No appeals will be considered.
Comments are not indexed in PubMed.

Specific requirements

Maximum length, 400 words
Entered as plain text or HTML
Author’s name and email address, to be posted with the comment
Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
Comments may not include figures

Submit a comment

Cyclic 3′,5′-adenosine monophosphate in human blood platelets: II. Effect of N6-2′-0-dibutyryl cyclic 3′,5′-adenosine monophosphate on platelet function

Cyclic 3′,5′-adenosine monophosphate in human blood platelets: II. Effect of N6-2′-0-dibutyryl cyclic 3′,5′-adenosine monophosphate on platelet function

Abstract

Authors

Guidelines

Specific requirements

Sign up for email alerts

Cyclic 3′,5′-adenosine monophosphate in human blood platelets: II. Effect of N⁶-2′-0-dibutyryl cyclic 3′,5′-adenosine monophosphate on platelet function

Cyclic 3′,5′-adenosine monophosphate in human blood platelets: II. Effect of N⁶-2′-0-dibutyryl cyclic 3′,5′-adenosine monophosphate on platelet function